Tremfya (guselkumab)

£3,510.00

Tremfya (guselkumab) is a medication used for the treatment of adult patients with moderate-to-severe plaque psoriasis and active psoriatic arthritis.

DISEASE INDICATIONS

Psoriasis

MANUFACTURER

Janssen Biotech

USAGE

Subcutaneous

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

  • Health Canada

  • Pharmaceuticals and Medical Devices Agency (PMDA)

  • Therapeutic Goods Administration (TGA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

    WE CAN HELP WITH YOUR IMPORT DOCUMENTS

    We are experts in import regulations.

This content has been reviewed by a Medical Doctor.
TREMFYA (GUSELKUMAB) Package Single-dose pre-filled syringe

100 mg/ml guselkumab

Reviews

There are no reviews yet.

Be the first to review “Tremfya (guselkumab)”

Your email address will not be published. Required fields are marked *

Shopping Cart